Sharps Compliance Corp. (NASDAQ:SMED) shares reached a new 52-week low during trading on Friday . The stock traded as low as $3.40 and last traded at $3.54, with a volume of 1 shares traded. The stock had previously closed at $3.54.

SMED has been the topic of several research analyst reports. ValuEngine raised Sharps Compliance from a “sell” rating to a “hold” rating in a research report on Saturday, June 2nd. Zacks Investment Research lowered Sharps Compliance from a “hold” rating to a “strong sell” rating in a research report on Tuesday, May 1st. Stifel Nicolaus lowered Sharps Compliance from a “buy” rating to a “hold” rating and cut their price target for the stock from $6.00 to $4.00 in a research report on Monday, April 30th. Finally, TheStreet lowered Sharps Compliance from a “c-” rating to a “d+” rating in a research report on Wednesday, June 27th. Three research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $5.50.

The company has a debt-to-equity ratio of 0.06, a current ratio of 2.70 and a quick ratio of 2.02.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in SMED. Wells Fargo & Company MN acquired a new position in Sharps Compliance during the fourth quarter worth approximately $583,000. Renaissance Technologies LLC grew its stake in shares of Sharps Compliance by 8.3% in the 4th quarter. Renaissance Technologies LLC now owns 432,300 shares of the industrial products company’s stock valued at $1,768,000 after purchasing an additional 33,300 shares during the last quarter. Deutsche Bank AG grew its stake in shares of Sharps Compliance by 1,194.7% in the 4th quarter. Deutsche Bank AG now owns 28,484 shares of the industrial products company’s stock valued at $116,000 after purchasing an additional 26,284 shares during the last quarter. Thompson Davis & CO. Inc. grew its stake in shares of Sharps Compliance by 557.2% in the 1st quarter. Thompson Davis & CO. Inc. now owns 48,894 shares of the industrial products company’s stock valued at $222,000 after purchasing an additional 41,454 shares during the last quarter. Finally, Marathon Capital Management purchased a new position in shares of Sharps Compliance in the 1st quarter valued at approximately $249,000. 23.27% of the stock is currently owned by institutional investors.

Sharps Compliance Company Profile

Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste and used healthcare materials generated outside the hospital and health care facility settings; TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired prescription medications; and ComplianceTRAC, a Web-based compliance and training program.

Featured Story: How to Track your Portfolio in Google Finance

Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with MarketBeat.com's FREE daily email newsletter.